"Debating an Active Bill: Congressional Policy for Safe and Profitable BIological Generic Drugs"
A discussion of an active bill and the debate to balance company patent rights, stimulate innovation, develop cheaper drug alternatives, and guard patient safety.
Presented by Terry Lang
Tuesday, November 3rd
4:30-5:30 p.m.
521 Stanley Hall
* Cookies and coffee will be served *
Advance readings are available on the step website: http://step.berkeley.edu